ArticlePLOS global public health2025
Evaluation of the National cervical cancer surveillance program in Bangladesh: Performance, strengths, and opportunities for improvement.
Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical cancer (CC) is the second most prevalent cancer among women in Bangladesh, with 9,640 new cases and 5,826 deaths annually. Since 2018, the Electronic Data Tracking with Population-Based Cervical and Breast Cancer Screening Program (EPCBCSP) has been implemented nationwide across 601 health centers, utilizing Visual Inspection with Acetic Acid (VIA) for CC screening. However, the system had not been evaluated until now. This study aims to assess the performance of EPCBCSP and identify its strengths and challenges. We evaluated EPCBCSP using the updated guidelines from the Centers for Disease Control and Prevention(CDC) in 2023. Data were collected from central level stakeholders and from stakeholders at one colposcopy and one VIA center in each of four selected divisions of Bangladesh. Interviews with 42 stakeholders assessed simplicity, flexibility, acceptability, stability and usefulness attributes. Data quality was assessed by surveillance data review. Percentage scores were calculated and ranked as follows: excellent (≥ 90%), Very good (≥ 80%- < 90%.), good (≥60%- < 80%), average (≥50%- < 60%) and poor (≤50%).The overall system performance was rated as good (score:77.20%). The system's simplicity (score: 91.61%) and usefulness (score:91.61%) were ranked as "excellent". The acceptability (score: 85.29%) was ranked as "very good and flexibility (score:71.90%) was rated as "good". Stability (percentage score: 53.25%) was considered average. Furthermore, data quality was assessed as average based on missing values (13.11%.) Electronic data tracking system, instant test report availability and "see and treat" policies were identified as strengths by stakeholders, while dedicated staff shortages and motivating participants were main challenges. The evaluation EPCBCSP in Bangladesh indicates overall good performance, excelling in simplicity and usefulness. However, improvements are needed in stability and data quality. Strengthening surveillance efforts addressing shortages of dedicated staff and participant motivation will further enhance the effectiveness of the program, crucial for reducing CC burden.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.